I think we all share a viewpoint the market is under pricing the potential of radiopharmaceuticals in general and Cu6 in particular in the management of metastatic malignant disease. In some ways selling out early to BP deprives us of finding out what could be achieved
CU6 - ASX Charts, page-792
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.63 |
Change
-0.110(2.94%) |
Mkt cap ! $1.178B | |||
| Open | High | Low | Value | Volume |
| $3.81 | $3.81 | $3.62 | $4.501M | 1.213M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 5132 | $3.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.64 | 7780 | 27 |
View Market Depth
| Last trade - 15.45pm 31/01/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |